At a glance
ClinicalIndex Comparison RecordN/ACompleted· 237 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective, Non-interventional Study Assessing the Real-Life Use of The Long- Acting Gonadotropin-releasing Hormone Agonist as A Treatment for Locally Advanced or Meta-static Prostate Cancer in Hong Kong.
In Brief
An observational study for Prostate Cancer. Completed, enrolled 237 participants across 1 site.
Detailed Summary
It is a retrospective review of the electronic medical record of patients on long-acting triptorelin in Hong Kong.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesHong Kong
CollaboratorsIpsen
Timeline
N/ACompletedFinished
202420252026
Enrollment StartApr 2023
Primary CompletionJan 2024
First PostedJan 2024
TodayJul 2026
First PostedJan 22, 2024
Enrollment StartApr 1, 2023
Primary CompletionJan 4, 2024
TodayJul 1, 2026
Enrollment to primary: 9 monthsPosted 2.4 years ago